• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Maternal asthma associated with increased odds of spontaneous abortion

bys25qthea
February 23, 2013
in Chronic Disease, Obstetrics, Pulmonology
Reading Time: 3 mins read
Share on FacebookShare on Twitter

Feb 23rd- Asthmatic women were more likely to experience spontaneous abortion than healthy women.

[tabs tab1=”2MM Rundown” tab2= “2MM Full Report”]

[tab]

Image: CC/JHeilman

1. Asthmatic women were more likely to experience spontaneous abortion than healthy women.

2. Maternal age, teratogenic medications, hypertension and diabetes mellitus were also associated with increased odds of spontaneous abortion.

RELATED REPORTS

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

A landmark court ruling was associated with increased travel across state borders for abortion care

This retrospective cohort study evaluated the relationship between maternal asthma and abortion and found that maternal asthma was associated with significantly increased odds of spontaneous abortion. These findings suggest that improved control of asthma in women before and during pregnancy may reduce the risk of spontaneous abortion and need for therapeutic abortions.

These findings are limited by retrospective study design, which disallows insight into causality of the association between maternal asthma and abortion.  Additionally, the study was conducted in Quebec, which has a publicly funded health care system, such that results may not be generalizable to all U.S. populations. Strengths of the study include a large sample size allowing for significant comparisons within asthmatic subgroups.

Click to read the study in Human Reproduction

[/tab]

[tab]

Image: CC/JHeilman

1. Asthmatic women were more likely to experience spontaneous abortion than healthy women.

2. Maternal age, teratogenic medications, hypertension and diabetes mellitus were also associated with increased risk of spontaneous abortion.

This [retrospective cohort] study assessed the relationship between maternal asthma and abortion in a cohort of women pregnant between 1990 and 2002. All asthmatic women (n= 15107) and a random sample of non-asthmatic women (n=34331) in three health databases were included. Asthma exposure was defined as maternal diagnosis of asthma (filling ≥1 prescription for asthma medication in the two years prior to pregnancy) and was further stratified by disease severity (mild, moderate or severe) and level of control (controlled, uncontrolled). Outcomes assessed were spontaneous abortion, therapeutic abortion, and live birth.

Asthmatic women were more likely to experience spontaneous abortion (OR 1.41, CI 1.33-1.49) and less likely to have a therapeutic abortion (OR 0.92, CI 0.88-0.97). Among asthmatic women, uncontrolled asthma was associated with increased odds of spontaneous abortion (OR 1.26, CI 1.14-1.41) and therapeutic abortion (OR 1.11 CI 1.01-1.21). Numerous risk factors were associated with increased odds of spontaneous abortion: maternal age, socioeconomic status, previous abortions, teratogenic medications, hypertension and diabetes mellitus.

In sum: This retrospective cohort study evaluated the relationship between maternal asthma and abortion and found that maternal asthma was associated with significantly increased odds of spontaneous abortion. These findings suggest that improved control of asthma in women before and during pregnancy may reduce the risk of spontaneous abortion and need for therapeutic abortions.

These findings are limited by retrospective study design, which does not permit establishment of a causal link between maternal asthma and abortion.  Additionally, the study was conducted in Quebec, which has a publicly funded health care system, such that results may not be generalizable to all U.S. populations. Strengths of the study include a large sample size allowing for significant comparisons within asthmatic subgroups.

Click to read the study in Human Reproduction

By Denise Pong and Leah Hawkins

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

[/tab]

[/tabs]

Tags: abortionasthmadiabetesteratogens
Previous Post

Argus retinal prosthesis “bionic eye” significantly improves vision in blind patients

Next Post

Continuity in diabetes provider improves outcomes and decreases costs

RelatedReports

Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

September 10, 2026
Adalimumab aids in control of noninfectious uveitis
Chronic Disease

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

September 8, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Obstetrics

A landmark court ruling was associated with increased travel across state borders for abortion care

August 28, 2026
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

Medical or procedural abortion may not increase risk of psychotropic medication use after five years

July 27, 2026
Next Post

Continuity in diabetes provider improves outcomes and decreases costs

[Policy Statement] New recommendations on genetic testing for children released

Greater decline in chest compression quality in children vs. adults

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic exposure to particulate matter is associated with increased cardiovascular risk
  • Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans
  • FDA-cleared AI devices rarely have patient outcome data
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.